Search

Search Results

##search.searchResults.foundPlural##

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2191

PDF: 810

HTML: 22
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

897

PDF: 447

HTML: 15
Erythrodermic psoriasis treated with apremilast

John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

19-09-2016

https://doi.org/10.4081/dr.2016.6599

1927

PDF: 865

HTML: 597
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1593

PDF: 426

HTML: 70
Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

11-09-2023

https://doi.org/10.4081/dr.2023.9824

739

PDF: 414

HTML: 19
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

785

PDF: 410

HTML: 15
Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

21-11-2022

https://doi.org/10.4081/dr.2022.9492

1526

PDF: 589

HTML: 79
Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

Sanja Javor, Donatella Bignardi, Matteo Borro, Cesare Massone

29-08-2023

https://doi.org/10.4081/dr.2023.9819

890

PDF: 579

HTML: 10
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1169

PDF: 335

HTML: 38
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1220

PDF: 575

HTML: 137
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1389

PDF: 356

HTML: 20
Skin-directed therapy and biologic response modifiers in mycosis fungoides

Vieri Grandi, Virginia Alba Colantuono, Nicola Pimpinelli

07-05-2024

https://doi.org/10.4081/dr.2024.9926

449

PDF: 443
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1737

PDF: 614

HTML: 23
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

902

PDF: 470

HTML: 54
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1017

PDF: 716

HTML: 39
CD4/CD8 double-negative mycosis fungoides: a review

Khalid Nabil Nagshabandi, Abdulrahman Shadid, Asem Shadid, Nouf K. Almuhanna

12-04-2024

https://doi.org/10.4081/dr.2024.9908

2920

PDF: 509

SUPPLEMENTARY: 50

HTML: 11
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

960

PDF: 523

HTML: 18
Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

28-12-2021

https://doi.org/10.4081/dr.2022.9454

3981

PDF: 583

APPENDIX: 114

HTML: 11
Late reaction to ustekinumab infusion

Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

e2

09-09-2013

https://doi.org/10.4081/dr.2013.e2

3813

PDF: 589

HTML: 259
Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani

14-06-2023

https://doi.org/10.4081/dr.2023.9641

804

PDF: 408

HTML: 15
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

174

PDF: 94
Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

Catharina Margrethe Lerche, Hans Christian Wulf

e13

14-09-2010

https://doi.org/10.4081/dr.2010.e13

1979

PDF: 744

HTML: 164
The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination

Georgi Tchernev, Simona Kordeva, Heily Kirilova, Valentina Broshtilova

01-03-2023

https://doi.org/10.4081/dr.2023.9636

1071

PDF: 522

HTML: 57
Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob

09-01-2025

https://doi.org/10.4081/dr.2025.10105

102

PDF: 61
Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami

06-12-2024

https://doi.org/10.4081/dr.2024.10171

829

PDF: 196

1 - 25 of 31 items 1 2 > >>

Search

Search Results

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Erythrodermic psoriasis treated with apremilast

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Skin-directed therapy and biologic response modifiers in mycosis fungoides

Certolizumab to treat hidradenitis suppurativa

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

CD4/CD8 double-negative mycosis fungoides: a review

Erythrodermic psoriasis improved by tildrakizumab

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Late reaction to ustekinumab infusion

Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination

Refractory pityriasis rubra pilaris treated with abrocitinib

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

authors

reviewers

indexing

dermatopathology

Keywords